← All stocks

Artiva Biotherapeutics, Inc.

ARTV Net selling
CIK 0001817241 #3037 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$1.27M
$255.75K on a plan · $103.88K straight out of an exercise
Sold at will
$911.91K
4 of 7 sales
Net
−$1.27M
−$911.91K against sales at will

By person

11 insiders · 7 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Aslan Fred
Chief Executive Officer
$946.14K (2)
−$946.14K
1,604,765
$17.52M
+640.7%
Banerjee Subhashis
Chief Medical Officer
$116.15K (3) scheduled
−$116.15K
170,947
$1.87M
Horan Christopher
Chief Tech Operations Officer
$115.64K (1)
−$115.64K
323,084
$3.53M
+1,192%
Bush Jennifer
COO, CLO, Compliance Officer
$93.61K (1)
−$93.61K
374,529
$4.09M
+414.5%
RA CAPITAL MANAGEMENT, L.P. entity
Director
17,329,570
$189.17M
+99.3%
GC Corp. entity
10% owner
5,999,703
$65.49M
+31.4%
Huston Thad Allen
Chief Financial Officer
220,000
$2.40M
Raymon Heather
SVP, Research and Development
148,228
$1.62M
+1,382%
Miralles Gines Diego
President & Head of R&D
122,500
$1.34M
Krishnamohan Neha
Chief Financial Officer
99,356
$1.08M
+98.7%
Graef Thorsten
Chief Medical Officer
80,000
$873.26K
+300.0%

No percentages here. This company's share count has moved by a factor of 2.0 over the window, from 24,289,328 to 48,890,121 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Banerjee Subhashis
27 Aug 2026
Chief Medical Officer
Sold after exercise
8,222
$12.01
$98.74K
Banerjee Subhashis
18 Aug 2026
Chief Medical Officer
Sold after exercise
429
$12.00
$5.15K

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 2
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 320,735
History held since 22 Jul 2024